Kezar Life Sciences, Inc. (KZR) Shares Outstanding (2017 - 2026)

Kezar Life Sciences has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $7.4 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 0.94% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.4 million (up 0.94% YoY) and the FY2025 annual result came in at $7.3 million, changed 0.38% from the prior year.
• Shares Outstanding (Entity) rose to $7.4 million in Q1 2026 per KZR's latest filing, from $7.3 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $7.4 million in Q1 2026 and troughed at $6.0 million in Q1 2022.
• A 5-year average of $7.1 million and a median of $7.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) soared 41.95% in 2022, then climbed 0.35% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $6.8 million in 2022, then grew by 6.26% to $7.3 million in 2023, then grew by 0.35% to $7.3 million in 2024, then climbed by 0.38% to $7.3 million in 2025, then rose by 0.58% to $7.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $7.4 million, $7.3 million, and $7.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.